Department of Epidemiology, School of Public Health, The Fourth Military Medical University, Xi'an, Shaanxi, 710032, China; Academy of Preventive Medicine, Shandong University, Jinan, China; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, China.
Academy of Preventive Medicine, Shandong University, Jinan, China; Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, China.
Int J Infect Dis. 2017 Aug;61:13-19. doi: 10.1016/j.ijid.2017.05.015. Epub 2017 May 31.
Tremendous progress has been made in hepatitis B virus (HBV) prevention and control in the last 30 years in China, but it continues to be a major public health problem. The most recently reported population-based seroepidemiological survey on HBV in Shandong Province in China was published in 2006, and an updated baseline for HBV prevalence was badly needed in the province to identify the change in HBV epidemiology in the last decade.
Two population-based cross-sectional serosurveys were performed among the population aged 1-59 years in the same sample areas in Shandong Province, China in 2006 and 2014, respectively. Data on demographic characteristics were collected. A blood sample was obtained from each person and was tested for hepatitis B surface antigen (HBsAg), antibody against HBsAg (anti-HBs), and antibody against hepatitis B core antigen (anti-HBc).
Overall, the prevalence rates of HBsAg, anti-HBs, and anti-HBc were 3.39% (95% confidence interval (CI) 2.51-4.26), 44.96% (95% CI 41.34-48.57), and 24.45% (95% CI 22.19-26.71), respectively, among the population aged 1-59 years in the 2006 serovsurvey; the corresponding prevalence rates were 2.49% (95% CI 1.81-3.17), 48.27% (95% CI 45.63-50.92), and 22.56% (95% CI 20.14-24.97), respectively, in 2014. The prevalence rates of HBsAg and anti-HBc were lower in 2014 than in 2006. Conversely, the prevalence of anti-HBs showed an increase. However, none of these differences were statistically significant (all p>0.05). The prevalence of HBsAg showed an increase among persons aged 20-24 years in 2014 (3.83%) compared with 2006 (2.98%) (t=0.45, p=0.67). Among all occupation groups, the prevalence of HBsAg was lower in 2014 than in 2006, while the prevalence of anti-HBc showed moderate increases in students and farmers (all p>0.05). The prevalence of HBsAg decreased more obviously in urban areas (65.49%) than rural areas (7.07%) from 2006 to 2014.
The epidemiology of HBV infection has changed in Shandong Province, China over the last decade. More attention should be paid to HBV infection among students and farmers.
在中国,过去 30 年来,乙型肝炎病毒 (HBV) 的预防和控制取得了巨大进展,但它仍是一个重大的公共卫生问题。中国山东省最近一次报道的基于人群的 HBV 血清流行病学调查是在 2006 年进行的,该省急需更新 HBV 流行率的基线数据,以确定过去十年中 HBV 流行病学的变化。
我们在中国山东省的同一采样地区分别于 2006 年和 2014 年对 1-59 岁人群进行了两次基于人群的横断面血清学调查。收集人口统计学特征数据。从每个人身上抽取一份血样,检测乙型肝炎表面抗原 (HBsAg)、抗乙型肝炎表面抗原抗体 (抗-HBs) 和抗乙型肝炎核心抗原抗体 (抗-HBc)。
2006 年血清学调查中,1-59 岁人群 HBsAg、抗-HBs 和抗-HBc 的总流行率分别为 3.39%(95%置信区间[CI]为 2.51-4.26)、44.96%(95% CI 为 41.34-48.57)和 24.45%(95% CI 为 22.19-26.71);2014 年,相应的流行率分别为 2.49%(95% CI 为 1.81-3.17)、48.27%(95% CI 为 45.63-50.92)和 22.56%(95% CI 为 20.14-24.97)。2014 年 HBsAg 和抗-HBc 的流行率低于 2006 年。相反,抗-HBs 的流行率有所增加。然而,这些差异均无统计学意义(均 P>0.05)。2014 年 20-24 岁人群 HBsAg 的流行率(3.83%)高于 2006 年(2.98%)(t=0.45,P=0.67)。在所有职业群体中,2014 年 HBsAg 的流行率低于 2006 年,而学生和农民的抗-HBc 流行率呈中度增加(均 P>0.05)。2006 年至 2014 年,HBsAg 在城市地区(65.49%)的下降幅度明显大于农村地区(7.07%)。
过去十年,中国山东省 HBV 感染的流行病学发生了变化。应更加关注学生和农民的 HBV 感染。